Earnings Call · Q4 FY2022·2023-02-25

Q4 22EPS +4.76%·Rev n/aQ3 22EPS -5.33%·Rev n/aQ2 22EPS -13.04%·Rev n/aQ1 22EPS -5.97%·Rev n/a⚠ consensus missing

Kymera Therapeutics, Inc. KYMR

Bruce Jacobs — Chief Financial Officer

Nello Mainolfi — Founder President and Chief Executive Officer

Jared Gollob — Chief Medical Officer

+5.2%1d on move date+4.6% vs SPY3d+1.3%5d+1.7%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more KYMR calls or request research access.

More KYMR calls Browse calls Request research access